Pharma News
-
![Legendary Bio submitted a supplemental application to the FDA to expand the indication for CARVYKTI®]( "Legendary Bio submitted a supplemental application to the FDA to expand the indication for CARVYKTI®")
Legendary Bio submitted a supplemental application to the FDA to expand the indication for CARVYKTI®
2023-06-08Legendary Bio submits a supplemental application to the U.S. FDA to expand the indication for CARVYKTI®.
-
![Beigene's Baiyueze ® won the Swiss Galen Prize 2023]( "Beigene's Baiyueze ® won the Swiss Galen Prize 2023")
Beigene's Baiyueze ® won the Swiss Galen Prize 2023
2023-06-08Baiyueze ® won the Galen Prize in 2023.
-
![Junshi Biosciences presented 26 research results of innovative tumor immune drugs at the 2023 annual meeting of the American Society of Clinical Oncology]( "Junshi Biosciences presented 26 research results of innovative tumor immune drugs at the 2023 annual meeting of the American Society of Clinical Oncology")
Junshi Biosciences presented 26 research results of innovative tumor immune drugs at the 2023 annual meeting of the American Society of Clinical Oncology
2023-06-08Junshi Biosciences presented 26 research results of innovative tumor immune drugs at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
-
![New indication for JansSEN SeDANOL ® Approved in China!]( "New indication for JansSEN SeDANOL ® Approved in China!")
New indication for JansSEN SeDANOL ® Approved in China!
2023-06-08Chinese psoriasis children welcome a new biologic treatment program!
-
![In the first May of 2023, 34 children's drugs received more approvals than in the same period last year]( "In the first May of 2023, 34 children's drugs received more approvals than in the same period last year")
In the first May of 2023, 34 children's drugs received more approvals than in the same period last year
2023-06-06The importance of drug use in children has gradually increased.
-
![In 2023 ASCO, a number of research data will be presented]( "In 2023 ASCO, a number of research data will be presented")
In 2023 ASCO, a number of research data will be presented
2023-06-06The new progress will be known first.
-
![Bayda Pharmaceutical BPI-16350 confirmed ORR up to 60.5%]( "Bayda Pharmaceutical BPI-16350 confirmed ORR up to 60.5%")
Bayda Pharmaceutical BPI-16350 confirmed ORR up to 60.5%
2023-06-06BPI-16350 confirmed ORR up to 60.5%! It is expected to be a new treatment option for patients with HR+/HER2- advanced metastatic breast cancer
-
![The legendary Bio-Citagiorencel reduces the risk of disease progression or death by 74%]( "The legendary Bio-Citagiorencel reduces the risk of disease progression or death by 74%")
The legendary Bio-Citagiorencel reduces the risk of disease progression or death by 74%
2023-06-06Cedarkeolencel reduces the risk of disease progression or death by 74%.
-
![2-4 times more likely to quit smoking! Innovative therapies may hit the market, Who will be king in the $100 billion market?]( "2-4 times more likely to quit smoking! Innovative therapies may hit the market, Who will be king in the $100 billion market?")
2-4 times more likely to quit smoking! Innovative therapies may hit the market, Who will be king in the $100 billion market?
2023-06-06The "Romance of Three Drugs" for Smoking Cessation
-
!['Tripartite' change 'four countries for hegemony', BTK inhibitor who master ups and downs?]( "'Tripartite' change 'four countries for hegemony', BTK inhibitor who master ups and downs?")
'Tripartite' change 'four countries for hegemony', BTK inhibitor who master ups and downs?
2023-06-06Cumulative sales of nearly $50 billion.
-
![$60 billion market size! Market analysis of diabetes therapeutics]( "$60 billion market size! Market analysis of diabetes therapeutics")
$60 billion market size! Market analysis of diabetes therapeutics
2023-06-01Multiple indications of the same drug seem to be another secret of success for pharmaceutical companies, such as semaglutide.
-
![Bayda Pharmaceutical: Third Generation EGFR-TKI Befortini Sealant Tiliacsom (Semena ®) is approved for sale]( "Bayda Pharmaceutical: Third Generation EGFR-TKI Befortini Sealant Tiliacsom (Semena ®) is approved for sale")
Bayda Pharmaceutical: Third Generation EGFR-TKI Befortini Sealant Tiliacsom (Semena ®) is approved for sale
2023-06-01The latest developments in Bayda Pharmaceuticals.
-
![PD-1 agonist development progress inventory, which players on the agonist track?]( "PD-1 agonist development progress inventory, which players on the agonist track?")
PD-1 agonist development progress inventory, which players on the agonist track?
2023-06-01A New cure for self-avoidance?
-
![With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug]( "With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug")
With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug
2023-06-01When it comes to HIF-PHI drugs, chronic kidney disease anemia will come to mind without thinking.
-
![J. Med. Chem. | for new protein degradation molecules of KRAS mutations]( "J. Med. Chem. | for new protein degradation molecules of KRAS mutations")
J. Med. Chem. | for new protein degradation molecules of KRAS mutations
2023-06-01Novel protein degrading molecule for KRAS Mutation!
-
![Breakthrough and question, Will recombinant Collagen become the next 100 billion track]( "Breakthrough and question, Will recombinant Collagen become the next 100 billion track")
Breakthrough and question, Will recombinant Collagen become the next 100 billion track
2023-06-01Despite the skepticism, the effect of recombinant collagen is obvious.
-
![Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab]( "Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab")
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
2023-05-29Recently, Biofarma, an Indonesian pharmaceutical company jointly controlled by Ardian and the Scarpa family, announced a final agreement to acquire 100% equity in CDMO company US Pharma Lab.
-
![PHARMAC SOUTH]( "PHARMAC SOUTH")
-
![MEDEXPO KENYA 2023]( "MEDEXPO KENYA 2023")
MEDEXPO KENYA 2023
2023-05-16The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2023.
-
![ACS Med. Chem. Lett. | first not two aromatic amine MEK - PROTAC protein JiangXieJi P6b]( "ACS Med. Chem. Lett. | first not two aromatic amine MEK - PROTAC protein JiangXieJi P6b")
ACS Med. Chem. Lett. | first not two aromatic amine MEK - PROTAC protein JiangXieJi P6b
2023-05-16The first non-diarylamine MEK-PROTAC protein degrader P6b.
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
